CAREDX, INC. Capital Expenditures Incurred but Not yet Paid
CAREDX, INC. (CDNA) reported Capital Expenditures Incurred but Not yet Paid of $3.21 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-02-25
- CAREDX, INC. capital expenditures incurred but not yet paid for fiscal 2025 was $3.21M, a 406.95% increase from fiscal 2024.
- CAREDX, INC. capital expenditures incurred but not yet paid for fiscal 2024 was $633.00K, a 2.16% decline from fiscal 2023.
- CAREDX, INC. capital expenditures incurred but not yet paid for fiscal 2023 was $647.00K, a 54.53% decline from fiscal 2022.
- CAREDX, INC. capital expenditures incurred but not yet paid for fiscal 2022 was $1.42M, a 64.00% decline from fiscal 2021.
| Period end | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|
| 2025-12-31 | $3.21M 10-K · filed 2026-02-25 |
| 2024-12-31 | $633.00K 10-K · filed 2026-02-25 |
| 2023-12-31 | $647.00K 10-K · filed 2026-02-25 |
| 2022-12-31 | $1.42M 10-K · filed 2025-02-28 |
| 2021-12-31 | $3.95M 10-K · filed 2024-02-28 |
| 2020-12-31 | $274.00K 10-K · filed 2023-02-27 |
| 2019-12-31 | $576.00K 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |